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This perspective reviews single molecule and ensemble ﬂuorescence spectroscopy studies of the three
tissue speciﬁc nitric oxide synthase (NOS) isoenzymes and the related diﬂavin oxidoreductase cyto-
chrome P450 reductase. The focus is on the role of protein dynamics and the protein conformational
landscape and we discuss how recent ﬂuorescence-based studies have helped in illustrating how the
nature of the NOS conformational landscape relates to enzyme turnover and catalysis.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Many experimental and computational techniques have shown
the importance of protein conformational change in both cell sig-
nalling [1e4] and enzyme catalysis [5e9]. It is now commonly
believed that X-ray crystallography-derived structural data,
although valuable, is insufﬁcient in describing the function of many
proteins. This has led to the notion that the structure-function
dogma should be expanded to encompass protein dynamics
(structure-dynamics-function relationship) [10]. The dynamic
proﬁle of a protein can be thought of as a multidimensional
conformational landscape, which comprises of ‘hill’ and ‘valley’
features representing high and low energy protein sub-states,
respectively (Fig. 1) [10,11]. These population sub-states can be
easily perturbed, but also voluntarily controlled, by mutagenesis,
temperature, pressure, protein-protein interaction, redox chemis-
try and ligand/inhibitor binding [10].
The ﬁeld of protein dynamics is gaining increasing attention, as
greater insight into protein function is required, in order to be ablecytochrome P450 reductase;
ase; P450 BM3, cytochrome
ﬂavin mononucleotide; FRET,
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6/j.niox.2016.09.002to develop target-directed pharmaceuticals [12,13] and to rationally
design enzymes for bio-catalytic purposes [14,15]. However, the
study of conformational changes associated with enzyme turnover
is challenging, as dynamics occur over a broad range of time and
distance scales, from sub-Ångstrom localised vibrations (femto-
seconds) to large domain reorganisation (seconds) [9,16].
Nitric oxide synthase (NOS) is proposed to make deﬁned
conformational changes during catalysis. NOS produces the small
molecule nitric oxide (NO), which has a broad range of physiolog-
ical roles from vasodilation to neurotransmission [17]. The three
tissue speciﬁc NOS isoenzymes are homodimers that function by
transferring electrons, which originate fromNADPH, to the catalytic
NOS haem porphyrin centre. Each NOS monomer is made up of i) a
C-terminal reductase domain, comprising discrete FAD/NADP(H)
and FMN binding domains, ii) an N-terminal oxygenase domain,
which contains a tightly bound haem B and a tetrahydrobiopterin
(H4B) molecule and iii) a binding site for calmodulin (CaM), which
links the reductase and oxygenase domains (Fig. 2).
NOS is believed to shuttle between the so called ‘input’ and
‘output’ conformational states, which have different orientations of
the reductase and oxygenase domains [18]. These two states are
thought to be functionally relevant in ‘gating’ the precise ﬂux of
electrons from NADPH to the catalytic haem centre. In recent years
there has been a variety of spectroscopic approaches used to probe
NOS conformational change. Much of these data are summarised in
recently published review articles on the general biochemistry andunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
onformational control of electron transfer in nitric oxide synthases,
Fig. 1. Simpliﬁed two dimensional depiction of a multidimensional conformational
landscape of a protein molecule. The ‘valley’ features of the landscape represent (quasi)
stable conformational states that interconvert via higher energy barriers or ‘hills’
[10,11]. Temperature, pressure, mutagenesis, protein-protein interactions, reaction
chemistry and ligand/inhibitor binding all inﬂuence the conformational landscape of a
protein molecule (see text).
Fig. 2. Structure and molecular architecture of NOS. A) The structure of the NADPþ-bound neuronal NOS diﬂavin reductase domain (PDB ID 1TLL). B) The structure of holo-CaM
bound to a nNOS-peptide (PDB ID 2O60). C) The crystal structure of the nNOS oxygenase domain dimer (PDB ID 1ZVL). CaM binds between the oxygenase and reductase domains of
NOS. D) Structural organisation of the functional NOS dimer. The NOS FAD and FMN binding domains are shown in dark blue and light blue, respectively. CaM is shown in grey and
the NOS oxygenase domain is shown in red.
T.M. Hedison et al. / Nitric Oxide xxx (2016) 1e72biophysics of NOS [19e25]. Herein, as an alternative perspective,
we present how recently published ﬂuorescence spectroscopic data
have helped in illustrating the nature of the NOS conformational
landscape related to catalysis. We offer an overview of the infor-
mation gathered from single molecule and ensemble ﬂuorescence
spectroscopy studies for the three tissue speciﬁc NOS isoenzymes
and also for the related diﬂavin oxidoreductase cytochrome P450
reductase (CPR).
2. Structure of the NOS isoenzymes
Despite the lack of an atomistic structure of full length NOS, thePlease cite this article in press as: T.M. Hedison, et al., A perspective on
Nitric Oxide (2016), http://dx.doi.org/10.1016/j.niox.2016.09.002X-ray crystal structures of the individual NOS domains [18,26e30],
along with recently published cryo-EM data [31e33], have helped
to illustrate the structural organisation of this enzyme (Fig. 2). The
three tissue-speciﬁc NOS isoenzymes are homodimeric proteins
which bind and are activated by CaM. Each NOS reductase domain
contains distinct FAD and FMN binding subdomains (Fig. 2A) and
this domain is homologous to CPR, a microsomal membrane-bound
diﬂavin oxidoreductase, which transfers electrons to a multitude of
partner proteins, e.g. cognate cytochrome P450 enzymes (CYPs)
[34,35]. Other members of the diﬂavin oxidoreductase family
include methionine synthase reductase (MSR), a key enzyme in
folate and methionine metabolism [36] and the reductase domain
of the bacterial CYP cytochrome P450 BM3 (P450 BM3) [37].
The NOS reductase and oxygenase domains are connected by a
CaM binding site. All three NOS isoforms bind to CaM, which is
essential for NOS catalysis. However, the binding between both theconstitutive NOS (cNOS) proteins [neuronal NOS (nNOS) and
endothelial NOS (eNOS)] and CaM is Ca2þ dependent and revers-
ible, while inducible NOS (iNOS)-CaM interactions occur regardless
of intracellular calcium concentrations [20].
Many spectroscopic studies have shown the ﬂux of electrons in
NOS isoenzymes occurs from NADPH, through FAD and FMN co-
factors, to the catalytic haem centre where NO is produced (see
below). However, based on crystallographic data of the isolated
NOS reductase domain in complex with NADPþ, where the FAD and
FMN cofactors are in proximity, the electron transfer from reduc-
tase to oxygenase domains is thought not to be possible, due to the
occluded location of the FMN [18]. This structure suggests that aconformational control of electron transfer in nitric oxide synthases,
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tween the FAD and haem domains, is required for intra-NOS elec-
tron transfer. These types of large-scale domain dynamics have
been observed at atomistic detail in variants of CPR using X-ray
crystallographic techniques [38e40]. Moreover, this conforma-
tional control has recently been detected also in NOS using cryo-
electron microscopy (cryo-EM), which has provided low resolu-
tion information on the molecular architecture of the protein
[31e33].
3. Reaction mechanism of NOS
Due to the characteristic ﬂavin and haem absorbance features,
many UVeVis based spectroscopic approaches, from conventional
stopped-ﬂow techniques [41e44] to novel laser ﬂash photolysis
[45e49], have been used to probe NOS and related diﬂavin oxido-
reductase redox chemistry. Flavin reduction is typically monitored
in the stopped-ﬂow by rapidlymixing the enzymewith NADPH and
following the quenching of the ~450 nm oxidised ﬂavin feature or
the growth and decay of the semiquinone species [42,43,50]. Due to
the multiphasic nature of the stopped-ﬂow traces for NOS reduc-
tion, the assignment of chemical steps to individual phases
observed in the stopped-ﬂow has not been possible [42,43]. How-
ever, Scheme 1 shows the simpliﬁed mechanism for NADPH-driven
ﬂavin reduction, which has been advanced for NOS [42,43] and is
conceptually similar to that described for other related diﬂavin
oxidoreductases [50]. Upon binding of NADPH to NOS, a hydride
anion is transferred from the C4 position of the coenzyme to the N5
position of the oxidised NOS bound FAD cofactor. Following FAD
reduction, reducing equivalents are transferred from the FAD hy-
droquinone to FMN, yielding the so called ‘quasi-equilibrium’ (QE)
state - a thermodynamic equilibrium where electrons partition
between the FAD and FMN cofactors. In the QE state, three pre-
dominant redox states are present (FAD hydroquinone and FMN
oxidised; FAD semiquinone and FMN semiquinone; FAD oxidised
and FMN hydroquinone). Following QE state formation, a second
NADPH coenzyme binds to NOS and drives the equilibrium towards
the FAD and FMN hydroquinone species.
The role of CaM during ﬂavin reduction has been investigated. In
full length nNOS [43], and in studies of isolated nNOS reductase
domain [42], the binding of CaM has only small/marginal effects on
the observed rates of interﬂavin electron transfer. However, CaM
binding does alter themid-point potential of NOS bound ﬂavin [51],
which will perturb the QE state and likely contributes to stimulated
rates of cytochrome c reduction in steady-state assays in the
presence of CaM [41e44].Scheme 1. Simpliﬁed reductive half reaction of nitric oxide synthase
Please cite this article in press as: T.M. Hedison, et al., A perspective on c
Nitric Oxide (2016), http://dx.doi.org/10.1016/j.niox.2016.09.002The chemistry catalysed by diﬂavin oxidoreductases diverges to
some extent after FMN reduction. CPR and MSR transfer reducing
equivalents from FMN to their respective partner proteins, while
NOS and cytochrome P450 BM3 (P450 BM3) shuttle electrons from
reduced FMN to their haem binding oxygenase domain. For NOS
catalysis, the transfer of electrons from reduced FMN to haem is
thought to be cross-monomer [52,53] and requires the presence of
CaM [54]. This FMN to haem electron transfer is difﬁcult to study by
stopped-ﬂow based methods due to the slow rate of electron de-
livery along with the complexity of transients recorded. Thus, novel
laser ﬂash photolysis approaches, which can rapidly inject elec-
trons into complex redox systems, have been used to track NOS
FMN to haem electron transfer. In particular, studies of FMN to
haem electron transfer using laser ﬂash photolysis of carbon
monoxide dissociation on partially reduced NOS have been used to
access the dynamics and the chemistry catalysed by the enzyme.
These measurements were initially performed on the truncated
NOSoxyFMN construct [46,47] and then subsequently on the full
length NOS enzyme [45,48,49]. Discrepancies between the rates
observed between these two forms of NOS constructs demon-
strated that shuttling between NOS input and output states (dy-
namic interconversion) is rate limiting in NOS catalysis, providing
evidence for a role of protein dynamics in gating NOS catalysis.
After sequential electron transfer from FMN to haem, the sig-
nalling molecule NO along with the amino acid L-citrulline is pro-
duced at the NOS oxygenase domain, from L-arginine and
molecular oxygen (Scheme 2) [55].
4. Domain dynamics of nitric oxide synthase (NOS)
4.1. Probing NOS dynamics using intrinsic ﬂavin ﬂuorescence
Using ﬂuorescence to probe changes in the microenvironment
of ﬂavin chromophores (FAD and FMN), which are non-covalently
bound to NOS, has proven to be a robust method of detecting
conformational change in diﬂavin oxidoreductases [56]. Gachhui
et al. [57] were the ﬁrst to investigate NOS conformational change
by observing FAD and FMN ﬂuorescence steady state emission. The
authors showed binding of Ca2þ/CaM to the nNOS reductase pro-
tein caused an increase in ﬂavin emission at ~530 nm, when
absorbance features of isoalloxazines were excited [57]. These CaM-
dependent alterations in ﬂavin emission have been observed in a
range of experiments and are attributed to an increase in solvent
exposure of the NOS FMN cofactor upon binding to CaM [51,58,59].
NADPþ binding has the opposite effect on NOS ﬂavin ﬂuorescence
[51]. These data suggest that CaM binding promotesand related diﬂavin oxidoreductases (see text for more details).
onformational control of electron transfer in nitric oxide synthases,
Scheme 2. The sequential oxidation of L-arginine (L-Arg) into NO and L-citrulline (L-
Cit) catalysed by NOS. Initially L-Arg is oxidised to N-hydroxy-L-arginine (NHA) which
is further oxidised to L-Cit and NO. Electrons transfer from the NOS FMN hydroquinone
to the NOS oxygenase domain is thought to be cross dimer and only occurs when CaM
is bound.
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binding hinders this mobility. This basic idea is consistent with a
number of reports that suggest an auto-inhibitory loop and a C-
terminal tail region of NOSmake contact with the NADP(H) binding
site [44,60e63]. In cNOS isoforms this interaction between coen-
zyme and the protein prevents movement of the FAD and FMN
domains, ﬁxing the protein in the ‘input’ state. When CaM binds to
cNOS, this interaction is disrupted, enabling conformational
freedom of the FMN domain. Overall, these steady-state ﬂuores-
cence measurements have been useful in detecting how muta-
genesis alters the conformational landscape of the enzyme, as well
as showing that shuttling of the FMN domain between the ‘input’
and ‘output’ states limits catalysis (e.g. as demonstrated using
solvent viscosity studies) [58,59].
The study of NOS by ﬂavin ﬂuorescence lifetime decay mea-
surements offers additional information on protein conformational
change over steady state ﬂuorescence emission measurements.
Flavin lifetime measurements were ﬁrst used to study the neuronal
NOS (nNOS) holoenzyme. These studies showed that the recorded
ﬂavin ﬂuorescence decay ﬁts to a multiexponential model, indi-
cating the presence of multiple ﬂavin microenviroments (confor-
mations) which do not interconvert on the ﬂuorescence timescale
[64]. Both cofactors (H4B and haem) and CaM/Ca2þ dependent
changes in the ﬂuorescence lifetime decays were observed, giving
clues into how the nNOS oxygenase and reductase domains fold
back onto one another and into the role of CaM in shuttling the
FMN domain [64]. Cryo-EM structure of the full length enzyme
[31e33] has recently conﬁrmed what was inferred from this ﬂuo-
rescence study thereby demonstrating the capabilities of ﬂuores-
cence spectroscopy to detect dynamic changes.
NOS ﬂuorescence lifetimes were recently revisited by Salerno
and co-workers [65,66]. The authors probed the differences be-
tween the iNOS holoenzyme and the iNOSoxyFMN complex,
allowing them to assign speciﬁc phases seen in the multi-
exponential ﬂuorescence lifetime decay to certain conformational
states related to NOS catalysis [66]. This was taken further inPlease cite this article in press as: T.M. Hedison, et al., A perspective on
Nitric Oxide (2016), http://dx.doi.org/10.1016/j.niox.2016.09.002subsequent work published by the same authors on the nNOS
isoform [65]. Combined, these studies with iNOS and nNOS showed
the presence of three major conformational states of the NOS en-
zymes. Two of these states are the well-deﬁned ‘input’ (lifetime of
~100 ps) and ‘output’ (lifetime of ~1 ns) states, where the FMN
domain is closer to the FAD domain or haem domain, respectively.
The third state detected was deﬁned as an intermediate state
(‘open’ state with a lifetime of ~4.3 ns), where the FMN domain is
distanced from the FAD and the haem domains. This ‘open’ state
was reported to be heterogeneous (tail of ﬂuorescence decays could
ﬁt to both single and multiple exponential functions) [65] and
similar to recently published cryo-EM [31e33] and EPR [67e69]
studies. These studies therefore reveal the complex and rugged
nature of the NOS conformational landscape, which is also altered
by CaM binding.
4.2. Probing NOS dynamics using external CaM-bound ﬂuorophore
ﬂuorescence
The commercial availability of extrinsic cysteine and lysine-
binding ﬂuorophores has signiﬁcantly contributed towards the
understanding of protein conformational change. Labelling a pro-
tein with ﬂuorophores in speciﬁc locations enables one to probe
conformational change by a number of ﬂuorescence based
methods. However, unlike CPR [34,35], NOS has multiple solvent
exposed cysteine and lysine residues, some of which are crucial for
structural integrity. Therefore, it is challenging to site-speciﬁcally
label NOS with extrinsic ﬂuorophores [70]. Alternatively, wild-
type CaM does not have any innate cysteine residues, so site-
speciﬁc labelling of CaM variants offers a tractable approach to
the study of CaM-NOS dynamics by ﬂuorescence spectroscopy.
A number of well characterised CaM Cys knock-in variants have
been created that can be labelled with extrinsic ﬂuorophores
[43,68,71e75]. These variants, which have no reported effect on
NOS turnover, have been used to study the kinetics of CaM-NOS
association as well as deciphering the antiparallel-orientation (N-
terminal of NOS binds to C-terminal of CaM and vice versa) and the
compact conﬁguration (short distance between C- and N-terminal)
that CaM adopts when bound to NOS enzymes [74,75]. However,
much of this work has focused on the use of truncated versions of
NOS and there has been little focus on the interactions between full
length NOS and CaM. In an attempt to assess any differences in the
redox-dependent association of CaM and nNOS, we have labelled
one of these commonly used CaM variants (T34C-CaM) with the
cysteine binding Alexa-647 maleimide ﬂuorophore. In this study
the T34C-CaM bound Alexa-647 maleimide ﬂuorescence was seen
to quench upon binding to nNOS, likely due to F€orster resonance
energy transfer (FRET) from the ﬂuorophore to chromophore(s) in
nNOS. Fig. 3 shows the titrations of Alexa-647 labelled T34C-CaM
with both oxidised and aerobic dithionite-reduced nNOS. Due to
the complex nature of the tight binding between CaM and nNOS, as
well as the presence of different NOS-CaM binding states (previ-
ously observed by EPR [68], ﬂuorescence lifetime and single-
molecule studies [72]), dissociation constants (Kd) values were
not calculated for the CaM-nNOS interaction. However, by inspec-
tion of the two different CaM-nNOS titration curves, a clear varia-
tion can be observed. These data provide compelling evidence that
redox-chemistry drives conformational changes in the nNOS
enzyme, which in turn has a knock-on effect on CaM binding. These
redox-dependent conformational changes have been seen in the
related diﬂavin oxidoreductase CPR. When CPR is reduced to two-
or four-electron reduced forms, the FAD and FMN containing do-
mains move relative to one another, and similar behaviour could
explain why the interactions between NOS and CaM are altered by
redox chemistry [76,77]. We have recently probed the redox-conformational control of electron transfer in nitric oxide synthases,
Fig. 3. Redox-dependent binding of CaM to nNOS. A) shows the UVevisible absorbance spectra of oxidised (black) and dithionite-reduced (red) nNOS (~5 mM). The dithionite
reduced NOS was shown to be stable for over 2 h under air and the absorbance is not perturbed by the addition of a 5-fold excess of T34C-CaM (data not shown). B) shows the
titration of 5 nM A647-T34C-CaM with oxidised (black) and dithionite-reduced (red) nNOS monitored by quenching of the ﬂuorescence emission from the A647 bound to CaM. All
materials were of analytic grade and purchased from Sigma-Aldrich, except Alexa Fluor 647 C2 maleimide (A647)m which was purchased from Thermoﬁsher scientiﬁc. Both re-
combinant rat neuronal nitric oxide synthase and the T34C-CaM variant were expressed and puriﬁed as previously described [43,69,78,79]. Puriﬁed nNOS was oxidised with
ferricyanide and passed down a desalting column to remove excess oxidising agent. To reduce the oxidised nNOS, excess sodium dithionite mixed with the oxidised for of nNOS,
which was subsequently passed down a desalting column equilibrated with the buffering solution. A647 maleimide was bound to T34C-CaM in the dark using previously published
protocols [43]. Fluorescence measurements were made with an Edinburgh Instruments (Livingston, UK) FLS920 ﬂuorometer. Emission spectra were taken using 5 nm excitation and
5 nm emission slit-widths in 1 mL ﬂuorescent quartz cells (Starna Scientiﬁc Ltd, Hainault, UK) with a 10 mm excitation path length. Data were collected at room temperature in
40 mM HEPES (pH 7.6), 150 mM NaCl,1 mM CaCl2 and 10% glycerol. Under these conditions, no ﬂuorophore photo-bleaching was observed.
Fig. 4. nNOS-bound CaM dynamics and reaction chemistry are kinetically coupled. The graph shows the transient reaction chemistry of nNOS (relative absorbance, red) and
dynamics of nNOS-bound CaM (relative FRET efﬁciency, grey) recorded when mixing excess NADPH with nNOS (bound to CaM), under pseudo ﬁrst order conditions. The schematic
presented here shows the temporal resolved dynamics of nNOS-bound CaM when nNOS is reduced with NADPH. This ﬁgure is adapted in part from Ref. [43].
Fig. 5. CPR domain dynamics and reaction chemistry are kinetically coupled. The graph shows the transient reaction chemistry (relative absorbance, red) and dynamics (relative
FRET efﬁciency, blue) of CPR when mixing NADPH with the enzyme under pseudo ﬁrst order conditions. The schematic shows the structures of the ‘open’ (PDB ID 3ES9) and ‘closed’
(PDB ID 1AMO) CPR structures with the FAD and FMN binding domains in dark blue and light blue, respectively. This ﬁgure is adapted in part from Ref. [34].
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novel stopped-ﬂow FRET technique [43], which was initially
developed to track temporally-resolved changes in CPR domain
organisation (see section below [34,35]). We subsequently labelled
a double cysteine containing CaM variant (T34C/T110C-CaM) with
both donor and acceptor ﬂuorophores (Alexa 555 and Alexa 647).
By monitoring time-resolved changes in ﬂuorescence emission by
stopped-ﬂow spectroscopy, we were able to detect deﬁned
conformational changes in the CaM-NOS complex and showed that
CaM dynamics are kinetically coupled to key mechanistic steps
during nNOS turnover. These two ﬂuorescence studies show that
redox chemistry, along with cofactor binding, drives conforma-
tional change in the NOS enzymes, and is essential for ‘gating’
electron transfer fromNADPH to the NOS catalytic haem centre (see
Fig. 4).
4.3. Probing NOS dynamics using external NOS-bound ﬂuorphore
ﬂuorescence
As discussed above, wild-type NOS domain dynamics are difﬁ-
cult to probe using FRET-based experiments due to the high
number of potential ﬂuorophore labelling sites. Recently, He et al.
constructed a ‘Cys-lite’ variant of the NOS reductase domain [70]
that is unreactive towards maleimide ﬂuorophores. This subse-
quently enabled these authors to further mutate the variant to
allow the successful site-speciﬁcally labelling of NOS with ﬂuo-
rophores. Single molecule FRET measurements [70] were used to
monitor the distances between the nNOS FAD and FMN binding
domains, allowing the conformational landscape of NOS to be
probed. The main ﬁnding from this study is that CaM alters the
distribution of NOS conformational states, increasing the distances
between the FAD and FMN binding domains as well as increasing
the rate of conversion between protein sub-states and narrowing
the distribution of NOS conformers [70]. These alterations in the
NOS conformational landscape apparently enables the enzyme to
form more productive geometries, increasing the ﬂux of electrons
from NADPH to the haem catalytic centre, as is evident by the
stimulation of NOS catalytic activity by CaM [41,43,44].
CPR has far fewer solvent exposed cysteine residues than NOS (3
cf. 14) and can be labelled with two extrinsic ﬂuorophores [34].
Labelling of CPR with a mixture of donor and acceptor ﬂuorophores
allows the tracking of conformational changes that affect the FAD-
FMN separation [34,35] and we have used this approach to inves-
tigate single-turnover domain dynamics that occur during CPR
catalysis. Coenzyme (NADPþ) binding causes CPR to adopt a ‘closed’
conformation with shorter distances between the FAD and FMN
cofactors [35] and stopped-ﬂow experiments have illustrated that
CPR undergoes deﬁned conformational changes (‘opening’ and
‘closing’) during turnover, which appear to occur on the same
timescale as redox chemistry (Fig. 5) [34,35]. These time-resolved
domain dynamics of CPR had not been detected prior to these
measurements, and may play a role in gating electron transfers in
CPR as well as in the NOS isoenzymes.
5. Conclusions
Various studies of NOS and related diﬂavin reductases now give
a largely consistent picture where these enzymes exist in multiple
conformational states that can be described by a rugged confor-
mation landscape, which is perturbed by CaM and coenzyme
binding, ﬂavin (and possibly haem) redox state and also solvent
environment (viscosity, ionic strength, etc.). Stopped-ﬂow-based
FRET studies of CPR and CaM-nNOS have recently begun to show
how enzyme chemistry (ﬂavin reduction) maps onto conforma-
tional changes in these enzymes and now allows a mappingPlease cite this article in press as: T.M. Hedison, et al., A perspective on
Nitric Oxide (2016), http://dx.doi.org/10.1016/j.niox.2016.09.002between conformational and catalytic landscapes in diﬂavin
oxidoreductases.
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